2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Hodgkin Disease
65
Lymphoma
39
Urinary Bladder Neoplasms
16
Carcinoma, Non-Small-Cell Lung
11
Melanoma
9
Lung Neoplasms
9
Urethral Neoplasms
4
Recurrence
4
Prostatic Neoplasms
4
Lymphoma, Large-Cell, Anaplastic
4
Testicular Neoplasms
3
Neoplasms
3
Leukemia
3
Glioma
3
Central Nervous System Neoplasms
3
Astrocytoma
3
Testicular Germ Cell Tumor
2
Teratoma
2
Skin Neoplasms
2
Oligodendroglioma
2
Neurofibromatosis 1
2
Kidney Neoplasms
2
HIV Infections
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Ureteral Neoplasms
1
Survival Without Progression
1
Interventions
Vinblastine
1
Surveys and Questionnaires
1
Nivolumab
1
Cyclophosphamide
1
Cell- and Tissue-Based Therapy
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Childhood Solid Tumor
×
Vinblastine
×
Clear all
NCT03585465
2026-05-29
Metro-PD1
Centre Oscar Lambret
Phase 1/2
Terminated
63 enrolled